BERNENGO, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 11.936
EU - Europa 9.112
AS - Asia 5.042
SA - Sud America 313
AF - Africa 94
OC - Oceania 75
Continente sconosciuto - Info sul continente non disponibili 21
Totale 26.593
Nazione #
US - Stati Uniti d'America 11.688
CN - Cina 2.718
IT - Italia 2.446
IE - Irlanda 1.073
SG - Singapore 923
FR - Francia 915
DE - Germania 792
SE - Svezia 694
UA - Ucraina 681
FI - Finlandia 659
KR - Corea 596
AT - Austria 464
GB - Regno Unito 398
PL - Polonia 339
BR - Brasile 216
IN - India 216
CA - Canada 211
VN - Vietnam 159
JP - Giappone 136
DK - Danimarca 111
ES - Italia 111
NL - Olanda 69
AU - Australia 68
HK - Hong Kong 57
CH - Svizzera 56
GR - Grecia 56
TR - Turchia 56
BE - Belgio 53
SN - Senegal 50
RU - Federazione Russa 43
ID - Indonesia 42
CO - Colombia 29
AR - Argentina 28
MX - Messico 27
RO - Romania 25
PT - Portogallo 24
TW - Taiwan 24
NO - Norvegia 21
EU - Europa 20
CL - Cile 16
EG - Egitto 15
CZ - Repubblica Ceca 14
IR - Iran 13
TH - Thailandia 13
HR - Croazia 12
IL - Israele 11
AE - Emirati Arabi Uniti 10
HU - Ungheria 9
PE - Perù 9
RS - Serbia 8
UZ - Uzbekistan 8
BD - Bangladesh 7
EC - Ecuador 7
LV - Lettonia 7
MU - Mauritius 7
NZ - Nuova Zelanda 7
MO - Macao, regione amministrativa speciale della Cina 6
DZ - Algeria 5
MA - Marocco 5
SI - Slovenia 5
VE - Venezuela 5
ZA - Sudafrica 5
AL - Albania 4
IQ - Iraq 4
JO - Giordania 4
KW - Kuwait 4
LB - Libano 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
CR - Costa Rica 3
LT - Lituania 3
MY - Malesia 3
PA - Panama 3
PH - Filippine 3
QA - Qatar 3
SA - Arabia Saudita 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MK - Macedonia 2
NG - Nigeria 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
Totale 26.583
Città #
Beijing 2.101
Chandler 1.510
Dublin 1.067
Santa Clara 850
Villeurbanne 571
Singapore 567
Jacksonville 520
Houston 519
Princeton 455
Vienna 445
Ashburn 435
Medford 430
Ann Arbor 421
Fairfield 349
Dearborn 326
Wilmington 309
Warsaw 302
Columbus 292
Torino 292
Woodbridge 218
Milan 207
Redwood City 188
Nyköping 180
Cambridge 147
Seattle 144
Pisa 116
Boardman 107
Toronto 99
Pune 93
Rome 91
Boston 88
Dong Ket 86
Guangzhou 84
Fremont 78
Verona 68
Shanghai 60
Helsinki 58
Nanjing 55
New York 55
Washington 52
Falls Church 47
Lachine 44
Norwalk 43
Tokyo 43
Brussels 41
Hefei 41
Turin 39
Hong Kong 37
Jakarta 32
São Paulo 32
Napoli 31
Chengdu 30
Los Angeles 30
Athens 28
Jinan 28
Kunming 27
Des Moines 23
Florence 23
Munich 21
San Diego 21
Genova 19
Nuremberg 19
Paris 19
Saluzzo 19
Sydney 19
Chicago 17
Madrid 17
Bologna 16
Padova 16
Santiago 16
Buenos Aires 15
Mountain View 15
Nanchang 15
Ottawa 15
Phoenix 15
Brescia 14
Hangzhou 14
London 14
Duncan 13
Newcastle Upon Tyne 13
Palermo 13
Radomsko 13
Tianjin 13
Istanbul 12
Leiden 12
Melbourne 12
Redmond 12
Shenyang 12
Silver Spring 12
Zhengzhou 12
Zurich 12
Copenhagen 11
Rochester 11
Taipei 11
Baltimore 10
Dallas 10
Detroit 10
Hebei 10
San Mateo 10
Wuhan 10
Totale 15.244
Nome #
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. 740
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 621
Malattie bollose autoimmuni: casisitica clinica e approccio terapeutico 386
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 380
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 337
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 337
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 308
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 278
Atopic dermatitis in a phenylketonuric untreated patient 276
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 261
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus 261
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 256
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 251
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 246
Giornale italiano di Dermatologia e Venereologia 234
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 233
Patologie dermatologie e rischio di neoplasia in pazienti portatori di trapianto di rene: revisione della casistica torinese 223
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients 215
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. 213
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 212
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 200
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 197
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 187
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 187
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 181
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 179
Adult-onset cutaneous mastocytosis in monozygotic twins. 176
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 174
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 169
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 166
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 138
Prognostic differences across sexes in melanoma patients: What has changed from the past? 135
VENTI ANNI DI ESPERIENZA CON LA FOTOFERESI 134
BANS: a discussion of the problem. 132
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 132
microRNA-214 promotes melanoma tumor progression 130
L'elettrochemioterapia nel trattamento del sarcoma di Kaposi: l'esperienza di Roma e Torino 127
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 125
Fotoferesi: applicazioni terapeutiche “off-label” 120
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 117
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 117
A retrospective analysis of the costs and management of genital warts in Italy. 116
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 116
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 116
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 115
Functional properties in Sézary cells with an unusual phenotype. 113
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 113
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 112
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). 108
Detection of HIV p24 from antigen presenting monocytes for early diagnosis of HIV-1 infection. 108
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. 105
[Activity of deoxycytidylate-deaminase in human lymphocytes stimulated with phytohemagglutinin] 104
Multiple pyogenic granuloma of the penis. 104
A case of acute promyelocytic leukaemia with bullous, haemorrhagic and necrotic skin lesions. 103
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 103
EPILUMINESCENZA DIGITALE NEI MELANOMI SOTTILI: CORRELAZIONI CON I PARAMETRI CLINICO-PATOLOGICI 103
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)] 102
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 102
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 102
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 101
[Pemphigus-pemphigoid mixed bullous dermatosis in chronic lymphatic leukemia] 100
Melanoma maligno della congiuntiva con infiltrazione sclerale e metastasi mediastiniche: case report 100
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 99
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 99
Manifestazioni cutanee correlate al trattamento con imatinib mesilato in pazienti affetti da dermatofibrosarcoma protuberans 99
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 98
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 97
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 96
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 96
[Serum levels of soluble receptors of interleukin-2 in skin pathology] 95
Active rosette test in cutaneous lymphoproliferative disorders. 95
[Effect of methotrexate on DNA synthesis in human lymphocytes stimulated with phytohemagglutinin] 95
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)] 95
Immunomodulation and Sézary syndrome: experience with thymopentin (TP-5). 93
Adhesion molecules in lymphomatoid granulomatosis 92
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients 92
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of patients with warts. 92
Micosi fungoide: dall'istopatologia alla biologia molecolare 92
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies. 91
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 91
Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study. 90
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 90
The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up. 90
[Pemphigus induced by monoclonal IgM with anti-IgG antibody activity in a case of Waldenström's 's 's macroglobulinemia] 89
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 88
Le infezioni nella micosi fungoide e nella sindrome di Sézary 88
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 88
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. 87
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphea. 87
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 86
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 85
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients. 85
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 85
Linfociti Treg e fotoferesi 85
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 85
Electrochemotherapy in treatment of skin melanoma metastases 85
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 84
CD26 (DPP-IV)- A useful marker in Sezary sindrome 84
Leucosis and skin: acute lymphoid immunoblastic leukaemia. 83
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. 83
Totale 15.171
Categoria #
all - tutte 78.304
article - articoli 0
book - libri 0
conference - conferenze 27.243
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.051 0 0 0 0 0 0 0 0 353 275 220 203
2020/20212.424 393 137 186 137 204 157 182 93 254 232 191 258
2021/20222.499 63 92 138 135 150 106 161 123 86 131 484 830
2022/20234.440 621 274 105 351 492 1.110 388 265 445 78 209 102
2023/20241.764 231 293 124 98 119 244 68 67 18 83 126 293
2024/20253.039 68 351 152 434 1.267 227 156 263 121 0 0 0
Totale 27.541